ストックスクリーナーアプリを入手
5.8097
2.83%
0.1597
アフターアワーズ：
5.81
0.0003
+0.01%
前日終値:
$5.65
開ける：
$5.83
24時間の取引高:
12,442
Relative Volume:
0.79
時価総額：
$102.23M
収益：
$22.43M
当期純損益:
$-17.19M
株価収益率:
-4.3721
EPS:
-1.3288
ネットキャッシュフロー:
$-10.02M
1週間 パフォーマンス:
-1.53%
1か月 パフォーマンス:
-6.45%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.62
$6.00
1週間の範囲:
$5.45
$6.00
52週間の値動き範囲:
$4.7237
$6.89
Bioharvest Sciences Inc Stock (BHST) Company Profile
BHST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.8097 | 102.23M | 22.43M | -17.19M | -10.02M | -1.3288 |
|
KHC
Kraft Heinz Co
|
29.94 | 36.06B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
57.67 | 32.31B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.41 | 28.46B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
74.67 | 20.81B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
30.40 | 16.80B | 11.92B | 805.04M | 1.01B | 1.46 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-18 | 開始されました | Maxim Group | Buy |
Bioharvest Sciences Inc (BHST) 最新ニュース
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? - MSN
Research Analysts Set Expectations for BHST Q2 Earnings - The AM Reporter
Analysts Set Expectations for BHST Q1 Earnings - Defense World
What is HC Wainwright’s Estimate for BHST Q2 Earnings? - Defense World
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target - Investing.com Australia
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target By Investing.com - Investing.com Canada
BioHarvest Sciences’ (BHST) Buy Rating Reaffirmed at HC Wainwright - Defense World
Here's Why BioHarvest Sciences (NASDAQ:BHST) Can Afford Some Debt - simplywall.st
Q1 Earnings Forecast for BHST Issued By Diamond Equity - Defense World
BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion - TipRanks
BioHarvest Sciences Reports Strong Growth Amid Challenges - TipRanks
BioHarvest CEO talks Nasdaq uplisting, profit targetsICYMI - Proactive financial news
BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
BioHarvest Sciences reports record-breaking 2024 revenue and expansion milestones - Proactive financial news
Small cap wrap: Ideal Power, Voyageur Pharmaceuticals, North Bay Resources, Trust Stamp... - Proactive financial news
BioHarvest shares rise after Q4 results show strong demand for VINIA products - Proactive financial news
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates - MSN
BioHarvest Sciences Reports Strong Financial Growth and Strategic Partnership - TipRanks
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results - Newsfile
Contrasting CureVac (NASDAQ:CVAC) & BioHarvest Sciences (NASDAQ:BHST) - The AM Reporter
BioHarvest Sciences (BHST) to Release Earnings on Monday - Defense World
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength? - Nasdaq
BioHarvest Sciences to Announce Q4 and Full Year 2024 Financial Results - TipRanks
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time - Newsfile
BIOHARVEST SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive financial news
BioHarvest's VINIA sales top $50M, plans production boost By Investing.com - Investing.com Canada
BioHarvest’s VINIA Achieves $50 Million in Sales, Plans Major Expansion - TipRanks
BioHarvest's VINIA sales top $50M, plans production boost - Investing.com India
BioHarvest’s VINIA sales top $50M, plans production boost - Investing.com
BioHarvest’s VINIA sales top $50M, plans production boost By Investing.com - Investing.com Nigeria
Bioharvest Sciences Inc (BHST) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
0.11%
大文字化:
|
ボリューム (24 時間):